These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation. Fukudo M, Yano I, Shinsako K, Katsura T, Takada Y, Uemoto S, Inui K. J Clin Pharmacol; 2009 Jul; 49(7):789-97. PubMed ID: 19487492 [Abstract] [Full Text] [Related]
33. [Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation]. Hosonuma R, Fujiwara S, Sasazaki M, Hirata Y, Yamamoto C, Uesawa M, Oh I, Matsuyama T, Mori M, Ozawa K, Muroi K. Rinsho Ketsueki; 2012 Apr; 53(4):469-71. PubMed ID: 22687983 [Abstract] [Full Text] [Related]
34. Higher intracerebral concentration of tacrolimus after intermittent than continuous administration to rats. Sakamoto Y, Makuuchi M, Harihara Y, Imamura H, Sato H. Liver Transpl; 2001 Dec; 7(12):1071-6. PubMed ID: 11753909 [Abstract] [Full Text] [Related]
35. Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients. Sato K, Amada N, Sato T, Miura S, Ohashi Y, Sekiguchi S, Satomi S, Okazaki H. Clin Transplant; 2004 Oct; 18(5):585-90. PubMed ID: 15344965 [Abstract] [Full Text] [Related]
36. Sublingual tacrolimus: a pharmacokinetic evaluation pilot study. Tsapepas D, Saal S, Benkert S, Levine D, Delfin M, Cremers S, Amann S, Dadhania D, Kapur S, Aull M. Pharmacotherapy; 2013 Jan; 33(1):31-7. PubMed ID: 23307542 [Abstract] [Full Text] [Related]
37. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H. Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296 [Abstract] [Full Text] [Related]
38. Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients. Leather H, Boyette RM, Tian L, Wingard JR. Biol Blood Marrow Transplant; 2006 Mar; 12(3):325-34. PubMed ID: 16503502 [Abstract] [Full Text] [Related]
39. Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease. Conrotto D, Carrozzo M, Ubertalli AV, Gandolfo S, Giaccone L, Boccadoro M, Bruno B. Transplantation; 2006 Oct 27; 82(8):1113-5. PubMed ID: 17060865 [No Abstract] [Full Text] [Related]
40. Tacrolimus disposition in the ascitic fluid of a bone marrow transplant patient. Ibrahim RB, Abidi MH, Al-Kadhimi Z, Uberti JP, Edwards DJ. Ann Pharmacother; 2010 May 27; 44(5):939-40. PubMed ID: 20371750 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]